Advancing Myelination Research: How iPSCs Are Transforming Multiple Sclerosis Drug Discovery
Studying oligodendrocytes has historically been challenging due to the complexity of isolating and culturing primary cells. A new iPSC-based model now allows for a more precise investigation of oligodendrocyte function, differentiation, and myelination, offering a promising tool for multiple sclerosis (MS) drug discovery.
